Coronary Artery Bypass Graft Market Size, Share, Growth, and Industry Analysis, By Type (On-Pump CABG,Off-Pump CABG), By Application (Hospital,Clinic), Regional Insights and Forecast to 2035

Coronary Artery Bypass Graft Market Overview

The global Coronary Artery Bypass Graft Market is forecast to expand from USD 149.18 million in 2026 to USD 155.28 million in 2027, and is expected to reach USD 214.05 million by 2035, growing at a CAGR of 4.09% over the forecast period.

The Coronary Artery Bypass Graft Market is witnessing steady growth due to the increasing prevalence of cardiovascular diseases, rising incidence of coronary artery blockages, and growing demand for advanced cardiac surgical procedures worldwide. The market is projected to grow at a CAGR of 4.09% during the forecast period, supported by the growing number of coronary artery bypass graft procedures performed globally each year. Coronary artery bypass grafting remains one of the most widely performed major cardiac surgeries, with approximately 400,000 CABG surgeries conducted annually worldwide. The procedure is extensively used to restore blood flow in patients suffering from severe coronary artery disease and continues to benefit from advancements in minimally invasive surgical techniques, robotic-assisted procedures, improved graft technologies, and enhanced postoperative care. Increasing geriatric populations, rising obesity levels, diabetes prevalence, and unhealthy lifestyle habits are further contributing to market growth globally.

In the United States, the Coronary Artery Bypass Graft Market remains highly significant due to the country’s large cardiovascular patient population and advanced healthcare infrastructure. Around 400,000 CABG procedures are performed annually in the U.S., accounting for more than 70% of all cardiac surgeries, highlighting the importance of the procedure in treating severe coronary artery disease. The country also records approximately 950,000 percutaneous coronary interventions annually, reflecting the substantial burden of cardiac disorders and the extensive adoption of interventional cardiology treatments. Increasing investments in cardiac care centers, technological advancements in surgical equipment, and growing emphasis on improving patient outcomes and reducing postoperative complications continue to support the expansion of CABG procedures across the United States.

What is Coronary Artery Bypass Graft (CABG)?

Coronary Artery Bypass Graft (CABG) is a surgical procedure used to restore normal blood flow to the heart in patients suffering from severe coronary artery disease. During the procedure, surgeons use healthy blood vessels taken from another part of the body to bypass blocked or narrowed coronary arteries. CABG is one of the most commonly performed major cardiac surgeries worldwide, with approximately 400,000 procedures conducted annually. The surgery helps reduce chest pain, improve heart function, and lower the risk of heart attacks in patients with advanced cardiovascular conditions.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 70 percent of cardiac surgery cases globally are isolated CABG procedures.
• Major Market Restraint: California CABG surgeries dropped from 62.2 to 49.8 per 100,000 adult population (representing a 20 percent decline).
• Emerging Trends: Minimally invasive CABG techniques are replacing full sternotomy in many procedures, with procedure types shifting; minimally invasive approaches now represent a significant portion in 2025.
• Regional Leadership: The United States conducts about 400,000 CABG surgeries per year, representing nearly 44 percent of global volumes.
• Competitive Landscape: The STS National Database captures 95 percent of adult cardiac procedures across 4,300+ surgeons, indicating robust participant coverage.
• Market Segmentation: On-pump and off-pump CABG types account for most procedures, with the on-pump segment dominating share in 2022 at roughly 55 percent.
• Recent Development: Multi-arterial grafting has demonstrated long-term survival benefits in follow-up of over 1 million patients over 10 years.

Coronary Artery Bypass Graft Market Latest Trends

The Coronary Artery Bypass Graft Market Trends reflect a steady procedural volume of roughly 400,000 CABG surgeries annually. The Coronary Artery Bypass Graft Market Research Report highlights isolated CABG representing over 70 percent of cardiac surgical cases. Utilization trends show an average of 36.7 CABG procedures per 100,000 population in a sample of 35 countries, with the US at approximately 64.5, indicating high process intensity.

Coronary Artery Bypass Graft Market Dynamics

The Coronary Artery Bypass Graft Market Dynamics highlight the complex interplay of clinical demand, technological advancements, and procedural shifts shaping the industry. With approximately 400,000 CABG surgeries performed globally each year and 70 percent of all cardiac surgeries being isolated bypass operations, the market is influenced by strong procedural demand.

DRIVER

"High procedural volume and clinical prevalence of CABG in ischemic heart disease."

In the context of Coronary Artery Bypass Graft Market Dynamics, the main driver of market growth is the consistently high procedural volume. Globally, about 400,000 CABG operations are performed annually, comprising over 70 percent of all cardiac surgeries. In the United States alone, CABG accounts for approximately 400,000 procedures per year out of about 950,000 cardiac interventions.

RESTRAINT

"Declining utilization per capita in some mature markets."

Market Restraints are evident in reduced utilization rates in regions like California, where CABG surgeries per 100,000 adult population declined from 62.2 in 2009 to 49.8 in 2022 a roughly 20 percent drop. Additionally, alternative procedures such as percutaneous coronary interventions now outnumber CABG by a margin: approximately 950,000 PCIs occur annually versus 400,000 CABGs in the US.

OPPORTUNITY

"Adoption of minimally invasive and multi-arterial CABG techniques."

Market Opportunities are evident in procedural innovation. Minimally invasive CABG methods increasingly replace full sternotomy, particularly by 2025, where a substantial share of open-heart surgeries are now minimally invasive. Multi-arterial grafting, assessed in a follow-up of 1 million patients over 10 years, demonstrates enhanced long-term survival and reduced cardiac events, offering benefits and driving interest in advanced graft strategies.

CHALLENGE

"Ensuring consistent quality and outcomes across high-volume centers."

A major Challenge in the market is maintaining surgical quality across widespread volume. While Cleveland Clinic reports observed operative mortality of 0.8 percent for isolated CABG, against STS-expected 1.2 percent, not all centers may match that performance. With the STS database covering 95 percent of adult cardiac surgeries, there is variability across providers.

Why is demand increasing for the Coronary Artery Bypass Graft Industry?

Demand for Coronary Artery Bypass Graft procedures is increasing due to the growing prevalence of cardiovascular diseases, rising cases of coronary artery blockages, and increasing aging populations globally. Lifestyle-related health issues such as obesity, diabetes, smoking, hypertension, and unhealthy dietary habits are significantly contributing to the rise in heart disease cases. CABG remains a critical treatment option for patients with severe coronary artery disease, especially those requiring long-term improvement in blood circulation. Advancements in minimally invasive surgery, robotic-assisted procedures, and improved postoperative care are further supporting the growing adoption of CABG procedures worldwide.

Coronary Artery Bypass Graft Market Segmentation

Segmentation by type and application reveals structured market divisions. Coronary Artery Bypass Graft Market Segmentation by type includes On-Pump CABG and Off-Pump CABG. On-Pump procedures, using heart-lung bypass circuits, dominated share in 2022, accounting for approximately 55 percent of procedures; Off-Pump CABG represents the remainder. By application, the market is segmented between Hospitals and Clinics. Hospitals handle the majority share, exceeding 60 percent of procedures, while cardiology clinics manage the balance.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

On-Pump CABG: On-Pump CABG is the traditional method employing a cardiopulmonary bypass machine and arrested heart. It remains dominant, accounting for around 55 percent of CABG procedures globally in 2022. This proportion reflects continued reliance on controlled surgical environments with cardiopulmonary support. On-Pump CABG utilizes conduits such as left internal mammary artery and saphenous vein grafts; additional conduits like right internal mammary artery, radial artery, and gastroepiploic artery are also utilized.

The On-Pump CABG segment: projected to reach USD 81.46 million in 2025 with a dominant 56.8% share, expanding further to USD 117.12 million by 2034 at a CAGR of 4.14%; growth is supported by high adoption in advanced cardiac centers, reliance on bypass support systems, and proven survival outcomes in complex procedures.

Top 5 Major Dominant Countries in the On-Pump CABG Segment

• United States: The market is valued at USD 32.11 million in 2025, representing 22.4% of global share, and is forecast to reach USD 45.82 million by 2034 at a CAGR of 4.10%; growth is fueled by the highest global procedural volume, advanced hospital networks, and widespread use of multi-arterial grafting techniques.
• Germany: The On-Pump CABG market is valued at USD 11.92 million in 2025, equal to 8.3% share, with projections of USD 17.16 million by 2034 at a CAGR of 4.14%; expansion is driven by strong clinical demand, robust surgical infrastructure, and consistent adoption of bypass technologies across specialized cardiovascular centers.
• Japan: The segment stands at USD 8.77 million in 2025, holding 6.1% market share, and is expected to reach USD 12.72 million by 2034 at a CAGR of 4.13%; growth is supported by its aging population, increasing ischemic heart disease prevalence, and advanced cardiac surgical practices across leading hospitals.
• United Kingdom: The market is valued at USD 7.59 million in 2025, contributing 5.3% share, and is set to expand to USD 11.02 million by 2034 at a CAGR of 4.12%; expansion is tied to high per-capita CABG procedure rates, established NHS surgical networks, and continuous adoption of advanced bypass techniques.
• India: Valued at USD 6.54 million in 2025, with 4.5% global share, and projected to rise to USD 9.49 million by 2034 at a CAGR of 4.14%; growth is driven by the increasing prevalence of coronary artery disease, expanding tertiary hospital capacities, and rising adoption of cardiopulmonary bypass machines in urban and regional centers.

Off-Pump CABG: Off-Pump CABG is performed on a beating heart without cardiopulmonary bypass support. It accounts for roughly 45 percent of CABG procedures globally in 2022. Off-Pump CABG is valued for potential reductions in complications associated with cardiopulmonary bypass, such as inflammatory responses.

The Off-Pump CABG segment: valued at USD 61.86 million in 2025 with a 43.2% share, projected to grow to USD 88.52 million by 2034 at a CAGR of 4.03%; expansion is supported by increasing adoption of beating-heart surgeries, reduced complications from bypass use, and rising acceptance of minimally invasive approaches worldwide.

Top 5 Major Dominant Countries in the Off-Pump CABG Segment

• United States: The market is valued at USD 24.17 million in 2025, accounting for 16.9% of global share, and projected to hit USD 34.27 million by 2034 at a CAGR of 4.02%; this growth is driven by high annual procedure volume, leading clinical expertise, and advanced stabilizer technologies that enhance surgical outcomes.
• Germany: Off-Pump CABG in Germany is worth USD 8.72 million in 2025, representing 6.1% share, and expected to reach USD 12.36 million by 2034 at a CAGR of 4.03%; steady growth reflects the country’s strong cardiovascular surgical network, patient demand for minimally invasive solutions, and government support for advanced surgical innovation.
• Japan: Valued at USD 7.54 million in 2025 with 5.3% global share, the segment is forecast to expand to USD 10.73 million by 2034 at a CAGR of 4.04%; expansion is supported by Japan’s aging demographics, high incidence of ischemic conditions, and well-established hospitals adopting Off-Pump technologies to reduce operative risks.
• United Kingdom: The UK market stands at USD 6.36 million in 2025, contributing 4.4% of global share, and forecast to rise to USD 9.08 million by 2034 at a CAGR of 4.02%; demand is bolstered by NHS cardiac surgery programs, patient preference for minimally invasive procedures, and expanding hybrid surgical centers.
• India: Valued at USD 5.83 million in 2025 with 4.0% share, India’s Off-Pump CABG market is projected to grow to USD 8.08 million by 2034 at a CAGR of 4.03%; rapid expansion is driven by rising cardiovascular disease prevalence, increasing clinical training in Off-Pump methods, and growing healthcare investments in urban hubs.

BY APPLICATION

Hospital: Hospitals serve as the primary application setting for CABG procedures, handling approximately 60 percent of all surgeries globally. With annual global volumes near 400,000 CABG operations, hospitals account for roughly 240,000 procedures. Hospitals provide comprehensive surgical infrastructure operating theaters, intensive care units, graft storage, and multidisciplinary teams making them the cornerstone of CABG delivery.

The Hospital segment: valued at USD 95.84 million in 2025 with the largest 66.9% market share, forecast to expand to USD 138.16 million by 2034 at a CAGR of 4.15%; growth is driven by advanced surgical infrastructure, the concentration of cardiovascular specialists, and the ability to manage complex On-Pump CABG procedures at scale.

Top 5 Major Dominant Countries in the Hospital Application

• United States: Hospitals dominate with USD 36.29 million in 2025, representing 25.3% global share, projected to rise to USD 52.19 million by 2034 at a CAGR of 4.14%; expansion is sustained by large hospital networks, high surgical volumes, and extensive use of multi-arterial grafting strategies in major centers.
• Germany: Valued at USD 12.77 million in 2025 with 8.9% share, the hospital market is expected to grow to USD 18.41 million by 2034 at a CAGR of 4.15%; growth is supported by strong government healthcare funding, advanced bypass facilities, and the dominance of tertiary care centers handling CABG operations.
• Japan: Hospitals in Japan account for USD 10.44 million in 2025, with 7.2% share, projected at USD 15.02 million by 2034 at a CAGR of 4.16%; rising procedure rates, an aging population, and high concentration of cardiac hospitals sustain this expansion.
• United Kingdom: Hospital market is valued at USD 8.96 million in 2025, with 6.2% global share, forecast to reach USD 12.87 million by 2034 at a CAGR of 4.14%; supported by NHS-backed cardiac programs, skilled surgeons, and strong infrastructure for On-Pump CABG.
• India: Worth USD 7.22 million in 2025 with 5.0% share, the hospital CABG market is expected to hit USD 10.67 million by 2034 at a CAGR of 4.15%; driven by hospital expansions in metro regions, government cardiovascular initiatives, and growing patient demand for advanced CABG solutions.

Clinic: Clinics, particularly specialized cardiology or outpatient surgical centers, account for the remaining 40 percent of CABG procedures globally approximately 160,000 surgeries annually. Clinics are more likely to adopt minimally invasive and Off-Pump techniques to reduce patient stay and resource utilization. By 2025, minimally invasive CABG methods are increasingly performed in clinic-based settings that support these less invasive approaches.

The Clinic segment: valued at USD 47.48 million in 2025 with a 33.1% market share, expected to expand to USD 67.48 million by 2034 at a CAGR of 4.00%; this growth is attributed to rising adoption of Off-Pump CABG, minimally invasive procedures, and hybrid surgery–PCI centers designed for efficiency and shorter patient recovery.

Top 5 Major Dominant Countries in the Clinic Application

• United States: Clinic CABG market valued at USD 20.01 million in 2025, representing 13.9% of global share, projected to grow to USD 28.35 million by 2034 at a CAGR of 4.01%; expansion is fueled by growing demand for minimally invasive procedures, strong clinic networks, and patient preference for reduced recovery time.
• Germany: Valued at USD 7.84 million in 2025 with 5.5% share, forecast to rise to USD 11.11 million by 2034 at a CAGR of 4.00%; growth is supported by specialized cardiology clinics, increasing procedural adoption outside hospitals, and robust integration of hybrid revascularization centers across the country.
• Japan: The clinic market holds USD 5.87 million in 2025, accounting for 4.1% global share, expected to reach USD 8.34 million by 2034 at a CAGR of 4.00%; this growth is linked to a focus on minimally invasive CABG, patient-centric care, and specialized outpatient cardiac centers.
• United Kingdom: Valued at USD 5.01 million in 2025 with 3.5% share, forecast to expand to USD 7.11 million by 2034 at a CAGR of 4.01%; supported by private clinic expansions, patient shift toward shorter hospital stays, and efficiency in minimally invasive surgical practices.
• India: The clinic CABG market is worth USD 4.37 million in 2025, contributing 3.0% global share, and is projected to grow to USD 6.13 million by 2034 at a CAGR of 4.00%; expansion is driven by growing cardiac clinic chains, adoption of Off-Pump techniques, and demand for cost-efficient bypass surgeries.

Regional Outlook for the Coronary Artery Bypass Graft Market

Regional performance varies significantly. North America leads CABG procedural volume, with the US performing approximately 400,000 surgeries annually and California rates around 49.8 per 100,000 adult population. Europe follows, with average CABG volumes between 36.7 per 100,000 population for sample countries. Asia-Pacific shows lower volumes (as low as 7.7 per 100,000 in South Korea), but rising demand. The Middle East & Africa region remains nascent in volume tracking but contributes to global procedural growth. These metrics form the Coronary Artery Bypass Graft Market Outlook across regions.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the Coronary Artery Bypass Graft Market in procedural volume. The United States alone performs approximately 400,000 CABG surgeries annually, which represent over 70 percent of all cardiac surgical cases. California’s utilization rate was 49.8 CABG surgeries per 100,000 adult population in 2022, down from 62.2 in 2009 indicating regional shifts even within this leading market.

The North America CABG market: valued at USD 54.86 million in 2025, holding the largest 38.3% global share, projected to expand to USD 78.83 million by 2034 at a CAGR of 4.08%; growth is supported by high procedural volumes, advanced cardiovascular infrastructure, and extensive adoption of multi-arterial grafting across hospitals and clinics.

North America – Major Dominant Countries in the Coronary Artery Bypass Graft Market

• United States: Market valued at USD 44.18 million in 2025, accounting for 30.8% share, rising to USD 63.00 million by 2034 at a CAGR of 4.09%; driven by 400,000 annual CABG procedures, strong surgical networks, and high utilization of both On-Pump and Off-Pump CABG.
• Canada: Valued at USD 6.71 million in 2025, holding 4.7% share, forecast to reach USD 9.55 million by 2034 at a CAGR of 4.08%; growth is supported by universal healthcare coverage, strong adoption of hospital-based CABG, and advanced cardiology centers concentrated in metropolitan provinces.
• Mexico: Market estimated at USD 3.97 million in 2025, representing 2.8% share, expanding to USD 5.72 million by 2034 at a CAGR of 4.09%; expansion is driven by rising ischemic heart disease prevalence, increasing surgical facilities, and growing investment in tertiary care centers.
• Cuba: The CABG market valued at USD 2.00 million in 2025, holding 1.4% share, projected to USD 2.86 million by 2034 at a CAGR of 4.07%; steady progress is linked to government-supported healthcare programs, surgical training initiatives, and gradual adoption of bypass procedures in regional hospitals.
• Puerto Rico: Valued at USD 1.00 million in 2025, representing 0.7% share, forecast to grow to USD 1.70 million by 2034 at a CAGR of 4.10%; growth is supported by partnerships with U.S. hospital networks and increased adoption of CABG in clinics offering specialized cardiovascular services.

EUROPE

Europe maintains substantial CABG procedural share within the Coronary Artery Bypass Graft Market. Average volumes across sampled countries are around 36.7 CABG per 100,000 population. Certain countries like Germany exhibit higher utilization, while others remain moderate. On-Pump CABG remains the prevalent approach, comprising approximately 55 percent of surgeries, supported by advanced hospital infrastructure. Clinics and cardiology centers also contribute, especially in urban areas, often performing minimally invasive or Off-Pump procedures.

The Europe CABG market: valued at USD 43.17 million in 2025, with 30.1% market share, projected to reach USD 61.86 million by 2034 at a CAGR of 4.08%; expansion is fueled by strong demand in Western Europe, government healthcare programs, and steady procedural volumes in countries with advanced cardiac surgery capacity.

Europe – Major Dominant Countries in the Coronary Artery Bypass Graft Market

• Germany: Market valued at USD 14.21 million in 2025, representing 9.9% share, growing to USD 20.37 million by 2034 at a CAGR of 4.09%; driven by high procedural volume, extensive hospital infrastructure, and a leading role in adopting advanced CABG techniques across Europe.
• United Kingdom: Estimated at USD 10.12 million in 2025, with 7.1% share, expected to expand to USD 14.51 million by 2034 at a CAGR of 4.08%; growth is supported by NHS cardiac surgery programs, high per-capita CABG procedure rates, and consistent investment in hybrid revascularization centers.
• France: The market is worth USD 7.96 million in 2025, representing 5.6% share, projected to rise to USD 11.39 million by 2034 at a CAGR of 4.09%; steady demand is supported by robust healthcare spending, advanced cardiac hospitals, and adoption of multi-arterial grafting techniques.
• Italy: Valued at USD 6.47 million in 2025, holding 4.5% share, forecast to grow to USD 9.25 million by 2034 at a CAGR of 4.10%; growth is linked to an aging population, increased ischemic heart disease burden, and expanding cardiovascular centers across northern Italy.
• Spain: Market estimated at USD 4.41 million in 2025, with 3.1% share, expected to hit USD 6.34 million by 2034 at a CAGR of 4.08%; expansion is supported by increased cardiac programs, high patient demand for minimally invasive CABG, and improved hospital capacities.

ASIA-PACIFIC

Asia-Pacific presents a growing segment within the Coronary Artery Bypass Graft Market. Average CABG volumes in sampled countries are about 36.7 per 100,000 population overall, though countries like South Korea report as low as 7.7 per 100,000, while others are higher, reflecting wide disparities. Population scale implies that even low per-capita rates contribute significant absolute volumes. Countries such as China and India show rising procedural numbers, driven by increasing cardiovascular disease prevalence and improved healthcare infrastructure.

The Asia CABG market: valued at USD 30.16 million in 2025, with 21.0% share, expected to grow to USD 42.96 million by 2034 at a CAGR of 4.09%; growth is driven by rising cardiovascular disease prevalence, rapid healthcare infrastructure expansion, and increasing adoption of advanced CABG procedures in emerging economies.

Asia – Major Dominant Countries in the Coronary Artery Bypass Graft Market

• China: Market valued at USD 11.09 million in 2025, holding 7.7% share, projected to reach USD 15.80 million by 2034 at a CAGR of 4.10%; growth reflects high disease burden, rapid hospital expansion, and increasing adoption of On-Pump CABG in urban centers.
• Japan: Valued at USD 10.31 million in 2025, accounting for 7.2% share, forecast to hit USD 14.68 million by 2034 at a CAGR of 4.08%; expansion is driven by its aging population, strong surgical expertise, and widespread availability of advanced CABG procedures.
• India: Market worth USD 5.27 million in 2025, with 3.7% share, projected to rise to USD 7.49 million by 2034 at a CAGR of 4.09%; growth is supported by an increasing cardiac disease burden, rising investments in tertiary hospitals, and growing adoption of cardiopulmonary bypass systems.
• South Korea: Estimated at USD 2.00 million in 2025, with 1.4% share, growing to USD 2.84 million by 2034 at a CAGR of 4.08%; expansion is fueled by technological adoption, specialized cardiac programs, and patient demand for minimally invasive CABG solutions.
• Indonesia: Market valued at USD 1.49 million in 2025, representing 1.0% share, projected to expand to USD 2.15 million by 2034 at a CAGR of 4.09%; growth is tied to rising heart disease prevalence, increasing hospital capacity, and government healthcare investments.

MIDDLE EAST & AFRICA

Middle East & Africa region currently contributes modestly to the global CABG procedural volume, given limitations in reporting and variable healthcare infrastructure. CABG surgeries per 100,000 population in many parts remain well below 36.7, likely under 10 per 100,000 in less resourced areas, with some urban centers showing higher numbers. The Coronary Artery Bypass Graft Market Outlook indicates growing investments in cardiac surgery capabilities, with select hospitals in Gulf states establishing advanced CABG programs.

The Middle East & Africa CABG market: valued at USD 15.13 million in 2025, with 10.6% share, expected to reach USD 21.99 million by 2034 at a CAGR of 4.10%; growth is supported by rising cardiac disease incidence, investments in advanced hospitals, and gradual adoption of bypass surgery in both public and private sectors.

Middle East & Africa – Major Dominant Countries in the Coronary Artery Bypass Graft Market

• Saudi Arabia: Market valued at USD 4.73 million in 2025, holding 3.3% share, projected to grow to USD 6.73 million by 2034 at a CAGR of 4.09%; growth is supported by advanced cardiac hospitals, strong investment in tertiary healthcare, and increasing adoption of On-Pump CABG.
• South Africa: Estimated at USD 3.41 million in 2025, representing 2.4% share, expanding to USD 4.87 million by 2034 at a CAGR of 4.08%; expansion is driven by a rising burden of ischemic disease, specialized hospital networks, and government-supported cardiovascular initiatives.
• UAE: The CABG market valued at USD 2.67 million in 2025, with 1.9% share, projected to hit USD 3.81 million by 2034 at a CAGR of 4.10%; growth is supported by strong private healthcare investment, advanced cardiac facilities in Dubai and Abu Dhabi, and increased patient inflow for medical tourism.
• Egypt: Valued at USD 2.11 million in 2025, contributing 1.5% share, expected to reach USD 3.01 million by 2034 at a CAGR of 4.09%; growth is linked to government-funded cardiac programs, expansion of teaching hospitals, and increasing availability of bypass procedures in urban centers.
• Nigeria: Market size USD 1.23 million in 2025, with 0.9% share, projected to USD 1.78 million by 2034 at a CAGR of 4.08%; growth is fueled by rising cardiovascular disease prevalence, investments in private healthcare, and expansion of surgical infrastructure in key urban regions.

Which region holds the largest market share?

North America holds the largest share in the Coronary Artery Bypass Graft industry, accounting for approximately 38.3% of the global market share. The region benefits from high procedural volumes, advanced cardiovascular healthcare infrastructure, strong hospital networks, and widespread adoption of advanced surgical technologies. The United States remains the leading contributor, performing nearly 400,000 CABG surgeries annually and representing a significant portion of global procedure volume. Increasing investments in cardiac care facilities, growing use of minimally invasive CABG techniques, and rising demand for advanced cardiovascular treatments continue to strengthen North America’s dominant market position.

List of Top Coronary Artery Bypass Graft Companies

• Vitalitec
• Edwards Lifesciences
• Genesee Biomedical
• Medtronic
• TERUMO
• Novadaq
• Sorin Group
• Guidant
• KARL STORZ
• MAQUET

Top Two Companies with Highest Market Share:

• Edwards Lifesciences: Recognized as one of the two top companies with highest procedural device utilization, with institutional presence across North America and Europe, contributing to over 20 percent share in device supply for CABG settings.
• Medtronic: Equally among the top two companies by market share, supplying bypass graft devices and surgical tools utilized in approximately 18 percent of CABG procedures globally.

Investment Analysis and Opportunities

In the Coronary Artery Bypass Graft Market Report context, investment analysis centers on procedural infrastructure and technological innovation. With approximately 400,000 CABG surgeries conducted annually and high concentrations in North America (44 percent share) and Europe (30 percent), investments in hospitals and clinics drive market opportunity.

New Product Development

New product development within the Coronary Artery Bypass Graft Market emphasizes innovations in grafting techniques and surgical tools. Multi-arterial grafting approaches, supported by data on 1 million patients with 10-year outcomes, have spurred development of novel arterial conduit kits and long-term patency instruments. Minimally invasive CABG methods, increasingly prevalent by 2025, led to the creation of advanced stabilizers, endoscopic vessel harvesting systems, and heart-positioning devices tailored for beating-heart surgery.

Five Recent Developments

• Multi-arterial grafting evaluated in a 10-year follow-up involving 1 million patients demonstrated improved long-term survival and reduced adverse cardiac events.
• By 2025, minimally invasive CABG approaches now perform many surgeries that previously required full sternotomy.
• STS National Database updated in 2023–2024, capturing nearly 10 million procedures from over 4,300 surgeons, covering 95 percent of adult cardiac surgeries.
• Cleveland Clinic reported operative mortality of 0.8 percent for isolated CABG (N=994), outperforming the 1.2 percent STS expectation in latest cycle.
• California’s CABG utilization decreased from 62.2 surgeries per 100,000 adult population in 2009 to 49.8 per 100,000 in 2022, reflecting utilization shift.

Report Coverage of Coronary Artery Bypass Graft Market

The Coronary Artery Bypass Graft Market Report covers a comprehensive scope spanning procedural volumes, type-based segmentation, application settings, regional performance, competitive landscape, and innovation trends. It includes analysis of approximately 400,000 CABG surgeries conducted annually, spanning On-Pump and Off-Pump procedures, with On-Pump comprising around 55 percent share. The report details application breakdown between hospitals (60 percent share) and clinics (40 percent share). Regional coverage spans North America, Europe, Asia-Pacific, and Middle East & Africa, with North America accounting for roughly 44 percent of volume, Europe 30 percent, Asia-Pacific growing from lower baselines (e.g., 7.7 per 100,000 in South Korea), and Middle East & Africa contributing under 10 percent.

Coronary Artery Bypass Graft Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 149.18 Million in 2026
Market Size Value By	USD 214.05 Million by 2035
Growth Rate	CAGR of 4.09% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : On-Pump CABG Off-Pump CABG By Application : Hospital Clinic
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample